Individuals with chronic obstructive pulmonary disease (COPD) with coexisting obstructive sleep apnea (OSAS) have greater ...

Chronic obstructive pulmonary disease (COPD) is known for causing breathing difficulties and limiting everyday activities.

53 percent) of the 30,000 people surveyed across 13 countries in December 2025 and January 2026 ranked sleep as the most important behavior for living a long, healthy life, ahead of eating a balanced ...

CEO Kevin Smith told investors at the KeyBanc Conference that the company has spent the past two years stabilizing operations ...

Peter Coates’s family welcome end to years pursuing answers after he died when outage stopped oxygen machine ...

Hunt Regional Healthcare recently announced the purchase of Pulmonary Associates of Greenville, calling it an effort to secure a critical medical care specialty in the region for the future. Dr.

The global pulmonary drug delivery technology market is projected to grow at a CAGR of approximately 5% over the next five years. This growth is driven by the rising prevalence of respiratory diseases ...

Understand why myasthenia gravis fatigue fluctuates throughout the day, and learn expert strategies to manage symptoms.

The FDA approved a proximal hypoglossal nerve stimulation device (aura6000 system) for adults with moderate to severe obstructive sleep apnea (OSA), maker LivaNova announced on Thursday. FDA's ...

Chronic obstructive pulmonary disease, or COPD, is the 5th-leading cause of death in the United States and the cause of more ...

Patients with COPD and heart failure treated with SGLT-2 inhibitors experienced higher rates of volume depletion and adverse renal events. Chronic obstructive pulmonary disease (COPD) reduces the ...

Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.